Higgons John Duncan

Avg. Two Year Performance

(73%) Avg. Purchase Return
(31%) Compound
29% Avg. Sale Return
14% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return48%75%(19%)50%(72%)
Purchase Success Rate1 of 11 of 10 of 11 of 10 of 1
Average Sale Return(< 1%)4%(1%)(5%)29%
Sale Success Rate12 of 2511 of 2511 of 2510 of 2515 of 25
Drugs » Biotechnology

Chief Operating Officer:

Holdings: 120.83K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 9.71K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--